- Home
- BMRA vs EPIX Comparison
BMRA vs EPIX Comparison
Compare BMRA & EPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRA
- EPIX
- Stock Information
- Founded
- BMRA 1971
- EPIX 2009
- Country
- BMRA United States
- EPIX Canada
- Employees
- BMRA N/A
- EPIX N/A
- Industry
- BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- EPIX Biotechnology: Pharmaceutical Preparations
- Sector
- BMRA Health Care
- EPIX Health Care
- Exchange
- BMRA Nasdaq
- EPIX Nasdaq
- Market Cap
- BMRA 8.2M
- EPIX 9.0M
- IPO Year
- BMRA N/A
- EPIX N/A
- Fundamental
- Price
- BMRA N/A
- EPIX $0.20
- Analyst Decision
- BMRA
- EPIX Hold
- Analyst Count
- BMRA 0
- EPIX 3
- Target Price
- BMRA N/A
- EPIX $2.00
- AVG Volume (30 Days)
- BMRA 33.1K
- EPIX 3.0M
- Earning Date
- BMRA 10-10-2025
- EPIX 08-13-2025
- Dividend Yield
- BMRA N/A
- EPIX N/A
- EPS Growth
- BMRA N/A
- EPIX N/A
- EPS
- BMRA N/A
- EPIX N/A
- Revenue
- BMRA $5,311,000.00
- EPIX N/A
- Revenue This Year
- BMRA N/A
- EPIX N/A
- Revenue Next Year
- BMRA N/A
- EPIX N/A
- P/E Ratio
- BMRA N/A
- EPIX N/A
- Revenue Growth
- BMRA N/A
- EPIX N/A
- 52 Week Low
- BMRA $2.08
- EPIX $0.18
- 52 Week High
- BMRA $10.16
- EPIX $6.45
- Technical
- Relative Strength Index (RSI)
- BMRA 45.61
- EPIX 11.88
- Support Level
- BMRA $2.68
- EPIX $0.20
- Resistance Level
- BMRA $2.83
- EPIX $0.22
- Average True Range (ATR)
- BMRA 0.11
- EPIX 0.01
- MACD
- BMRA 0.01
- EPIX 0.06
- Stochastic Oscillator
- BMRA 54.84
- EPIX 36.04
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.
About EPIX ESSA Pharma Inc.
ESSA Pharma Inc is a pharmaceutical company. The company was focused on the development of small-molecule drugs for the treatment of castration-resistant prostate cancer. It was developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival. Currently, the company has terminated its clinical trials and other studies.